We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PET-CT Identifies Cognitive Reserve in Early-Onset Alzheimer's Disease

By HospiMedica International staff writers
Posted on 19 May 2011
New findings have revealed that the "cognitive reserve" in early-onset Alzheimer's disease (AD) and positron emission tomography-computed tomography (PET-CT) imaging can be employed to effectively to identify early-onset AD patients. More...


"Although early-onset Alzheimer's dementia is quite rare, it can be devastating to the patients that carry the diagnosis," remarked Dr. Jacob Richard Hodge, lead researcher for this study from the Mayo Clinic (Rochester, MN, USA). "Symptoms are often unexpected and support networks are generally directed towards an older population."

In patients presenting with similar clinical severities of the disease, researchers found a cognitive reserve, which slowed the outward expression of symptoms. "Our research demonstrates that those patients with increasing education are better able to cope with the disease pathology before they express the symptoms of Alzheimer's dementia," Dr. Hodge said. This study evaluated PET-CT scans in 91 patients under age 65 to see if this cognitive reserve could be identified with early-onset AD, which often has a more aggressive course and progression.

Moreover, researchers replicated previously published data using PET-CT examinations, and they were able to detect significant abnormalities in patients with early-onset AD, thus validating its usefulness with younger patients. "Alzheimer's dementia is often not suspected in younger patients," Dr. Hodge said. "Therefore, PET-CT brain imaging can be helpful in the diagnosis."

Whereas the discovery of the cognitive reserve will not slow the progression of the disease, Dr. Hodge is confident that patients can improve the quality of their lives with the proper diagnosis and education. "Once the diagnosis is determined, a patient can begin to manage the disease and plan for the future," Dr. Hodge stated.

Dr. Hodge presented the findings of this study May 2, 2011, at the 2011 American Roentgen Ray Society (ARRS) annual meeting in Chicago (IL, USA).

Related Links:

Mayo Clinic




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.